Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New history entry added: Revision: v3.3.4 appears in the Record History alongside prior revisions.
    Difference
    0.1%
    Check dated 2026-01-14T02:13:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:24:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    New revision label v3.3.2 appears in the Record History, replacing the previous v3.2.0. This seems to be a routine site update and does not alter study data or core page content.
    Difference
    0.1%
    Check dated 2025-11-24T21:29:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The funding-status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T19:16:52.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The new screenshot adds an updated version entry in the Record History showing a change to the Study Status and related fields since the last version. This reflects progression of the trial's record over time.
    Difference
    0.1%
    Check dated 2025-11-03T13:50:37.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    12%
    Check dated 2025-10-06T04:23:53.000Z thumbnail image

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.